EUVIMEDEUVIMED entdecken
Crossref

Lilrb2-mediated inhibition of scleral remodeling in experimental myopia is associated with reduced intraocular inflammation and modulation of the MEK-ERK-P65 axis

Zhongyu Ma, Jiawen Hao, Zhaohui Yang, Miao Zhang, Yuan Peng, Jizhao Xin, Yuanting Yang, Mengke Wu, Xuewei Yin, Dadong Guo, Hongsheng Bi

European Journal of Pharmacology · 2026

DOI: 10.1016/j.ejphar.2025.178458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026. Verfasst von Zhongyu Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shandong University of Traditional Chinese Medicine, Jinan, 250002, China. Hauptthemen laut MEDLINE: Membrane Glycoproteins, Receptors, Immunologic, Myopia, Sclera. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Department of Science and Technology of Shandong Province, China Postdoctoral Science Foundation, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to investigate the role of leukocyte immunoglobulin-like receptor B2 (Lilrb2) in suppressing scleral remodeling in a guinea pig model of lens-induced myopia (LIM), with a focus on its ability to modulate the intraocular inflammatory microenvironment. METHODS: An LIM model was established in guinea pigs using -6.0 D lenses. Animals received an intravitreal injection of an adeno-associated virus overexpressing Lilrb2 (AAV-Lilrb2). Ocular biometric parameters were monitored. The activity of the MEK-ERK-P65 signaling pathway in the retina and the protein levels of MMP-2, collagen I, and α-SMA in the sclera were assessed using qPCR and Western blot. Macrophage polarization states were evaluated via multiplex immunofluorescence and Western blot analysis of iNOS (M1 marker) and ARG1 (M2 marker). Structural changes in the sclera were examined by H&E staining, while collagen organization and fibrosis were evaluated using Masson staining and immunofluorescence. RESULTS: Compared with the normal control (NC) group, the LIM group exhibited significant axial elongation and a myopic shift in refractive error. In the retina, LIM promoted M1 macrophage polarization, activated the MEK-ERK-P65 pathway, and elevated pro-inflammatory cytokine levels. In the sclera, M2 macrophage polarization was enhanced and accompanied by increased MMP-2 expression and reduced levels of α-SMA and collagen I. Histological analysis revealed disorganized collagen fibers and widened interfibrillar spaces in the LIM sclera, indicative of active scleral remodeling. These changes were effectively counteracted by Lilrb2 overexpression, which attenuated intraocular inflammation and suppressed scleral remodeling. CONCLUSION: Lilrb2 overexpression mitigates myopia progression by ameliorating intraocular inflammation and inhibiting scleral remodeling in a guinea pig model of LIM, highlighting its potential as a therapeutic target for myopia control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane GlycoproteinsReceptors, ImmunologicMyopiaScleraMAP Kinase Signaling SystemAnimalsGuinea PigsDisease Models, AnimalInflammationMacrophage ActivationCell PolarityMale

Stichwörter der Autor:innen

InflammationLilrb2MyopiaSclera remodeling

Substanzen

Membrane GlycoproteinsReceptors, Immunologic

Autor:innen und Institutionen

  • Shandong University of Traditional Chinese Medicine, Jinan, 250002, China.
  • Shandong University of Traditional Chinese Medicine, Jinan, 250002, China; Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250002, China.
  • Shandong Academy of Eye Disease Prevention and Therapy, Shandong Provincial Clinical Research Center of Ophthalmology and Children Visual Impairment Prevention and Control, Shandong Engineering Technology Research Cente…
  • Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250002, China; Shandong Academy of Eye Disease Prevention and Therapy, Shandong Provincial Clinical Research Center of Ophthalmology…

Förderung

  • Department of Science and Technology of Shandong Province
  • China Postdoctoral Science Foundation
  • National Key Research and Development Program of China
  • Natural Science Foundation of Shandong Province
  • Taishan Scholar Foundation of Shandong Province

Zitieren

APA

Ma, Z., Hao, J., Yang, Z., Zhang, M., Peng, Y., Xin, J., Yang, Y., Wu, M., Yin, X., Guo, D., & Bi, H. (2026). Lilrb2-mediated inhibition of scleral remodeling in experimental myopia is associated with reduced intraocular inflammation and modulation of the MEK-ERK-P65 axis. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178458

Vancouver

Ma Z, Hao J, Yang Z, Zhang M, Peng Y, Xin J, et al. Lilrb2-mediated inhibition of scleral remodeling in experimental myopia is associated with reduced intraocular inflammation and modulation of the MEK-ERK-P65 axis. European Journal of Pharmacology. 2026. doi:10.1016/j.ejphar.2025.178458

BibTeX
@article{Ma2026,
  author = {Ma, Zhongyu and Hao, Jiawen and Yang, Zhaohui and Zhang, Miao and Peng, Yuan and Xin, Jizhao and Yang, Yuanting and Wu, Mengke and Yin, Xuewei and Guo, Dadong and Bi, Hongsheng},
  title = {Lilrb2-mediated inhibition of scleral remodeling in experimental myopia is associated with reduced intraocular inflammation and modulation of the MEK-ERK-P65 axis},
  journal = {European Journal of Pharmacology},
  year = {2026},
  doi = {10.1016/j.ejphar.2025.178458}
}
Kostenlos starten →